Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome

By Billa Evangelia   Kapolla Niki   Nicopoulou Stamatina   Koukkou Eftychia   Venaki Evangelia   Milingos Spyros   Antsaklis Aristides   Adamopoulos Dimitrios  

Gynecological Endocrinology, Vol. 25, Iss. 7, 2009-07 ,pp. : 427-434

Informa Healthcare

Access to resources Recommend Favorite

Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome

By Cataldo Nicholas A.   Abbasi Fahim   McLaughlin Tracey L.   Basina Marina   Fechner Patricia Y.   Giudice Linda C.   Reaven Gerald M.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 109-120

Oxford University Press

Access to resources Recommend Favorite

Reproductive pathology. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome

By Cibula D.  

Human Reproduction, Vol. 15, Iss. 4, 2000-04 ,pp. : 785-789

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin

By Cibula D.  

Human Reproduction, Vol. 17, Iss. 1, 2002-01 ,pp. : 76-82

Oxford University Press

Access to resources Recommend Favorite

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome

By Tziomalos Konstantinos   Katsikis Ilias   Papadakis Efstathios   Kandaraki Eleni A.   Macut Djuro   Panidis Dimitrios  

Human Reproduction, Vol. 28, Iss. 3, 2013-03 ,pp. : 785-793

Oxford University Press

Access to resources Recommend Favorite